Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02100553Phase 1Completed
Phase 1, open-label trial of bazedoxifene + conjugated estrogens in vasomotor symptoms and postmenopausal osteoporosis (2 arms), sponsored by Pfizer. Primary endpoints: Area Under the Curve From Time Zero to Extrapolated Infinite Time up to 96 hours and Maximum Observed Plasma Concentration up to 96 hours. Started Apr 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02100553.